Brilliant....whats not to like about this presentation especially with the focus of "targeting human neurodegenerative diseases" headlining the first slide.
My only query is the meetings would have greater impact if they had the MEND top line results when talking to potential investors/partners. Who knows perhaps they are about to drop.
Well done PAA...concise and to the point. "The Team" certainly reads well with the new appointments
Ann: Investor Presentation and Non-Deal Roadshow, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.020(9.30%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $562.4K | 2.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64065 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 115000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |